The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages

The aim of the study is to investigate activity of markers of oxidative and nitrosative stresses in blood plasma of patients in the I–II stages of Parkinson’s disease (PD) and to determine correlations between their concentrations and severity of non-motor PD symptoms. Materials and methods. 67 p...

Full description

Bibliographic Details
Main Authors: A. V. Demchenko, V. V. Biriuk, A. V. Abramov
Format: Article
Language:English
Published: Zaporozhye State Medical University 2021-09-01
Series:Patologìâ
Subjects:
Online Access:http://pat.zsmu.edu.ua/article/view/233431/238838
_version_ 1818788569775341568
author A. V. Demchenko
V. V. Biriuk
A. V. Abramov
author_facet A. V. Demchenko
V. V. Biriuk
A. V. Abramov
author_sort A. V. Demchenko
collection DOAJ
description The aim of the study is to investigate activity of markers of oxidative and nitrosative stresses in blood plasma of patients in the I–II stages of Parkinson’s disease (PD) and to determine correlations between their concentrations and severity of non-motor PD symptoms. Materials and methods. 67 patients at I–II PD stages and 20 healthy controls took part in the research. Cognitive functions were examined due to the Montreal Cognitive Assessment test – MoCA test. For the severity of psycho-emotional disorders evaluation the following scales and questionnaires were used: Night Sleep Assessment Questionnaire by A. M. Vein, Zung test for anxiety, apathy Starkstein scale, Boston stress-resistance test, Beck Depression Inventory (BDI-II). We performed ELISA test for determination of glutathione peroxidase (GPx) and glutathione-S-transferase (GST) activities and 3-nitrotyrosine (3-NT) level in blood plasma of participants (Elabscience® kit). Results. The middle age of PD patients and healthy controls was 64.35 ± 1.22 and 66.40 ± 0.70 years, respectively. GPx activity in plasma of patients at І–ІІ PD stages was significantly lower than in healthy controls (P < 0.001) and was higher at the I stage compared to the II PD stage (P = 0.003). Also GPx activity in PD patients with normal cognition was higher than in PD patients with cognitive impairment (P = 0.042). The GST activity in plasma of PD patients with anxiety was significantly lower (P = 0.002) compared to those without anxiety, and 3-NT blood plasma level in PD patients with moderate anxiety was higher than in those without one (P = 0.029). Conclusions. The activity of antioxidant GPx was significantly lower in PD patients at early stages compared to healthy controls, and in PD patients in the II stage of the disease compared to the I stage, and it was significantly lower in PD patients with cognitive impairment. PD patients with moderate anxiety had lower 3-NT levels and GST activity in blood plasma.
first_indexed 2024-12-18T14:25:45Z
format Article
id doaj.art-95409c14e2be4c95b89ca700d039670b
institution Directory Open Access Journal
issn 2306-8027
2310-1237
language English
last_indexed 2024-12-18T14:25:45Z
publishDate 2021-09-01
publisher Zaporozhye State Medical University
record_format Article
series Patologìâ
spelling doaj.art-95409c14e2be4c95b89ca700d039670b2022-12-21T21:04:43ZengZaporozhye State Medical UniversityPatologìâ2306-80272310-12372021-09-0118218318810.14739/2310-1237.2021.2.233431The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stagesA. V. Demchenko0https://orcid.org/0000-0002-4296-0902V. V. Biriuk1https://orcid.org/0000-0001-8826-1536A. V. Abramov2Zaporizhzhia State Medical University, UkraineZaporizhzhia State Medical University, UkraineZaporizhzhia State Medical University, UkraineThe aim of the study is to investigate activity of markers of oxidative and nitrosative stresses in blood plasma of patients in the I–II stages of Parkinson’s disease (PD) and to determine correlations between their concentrations and severity of non-motor PD symptoms. Materials and methods. 67 patients at I–II PD stages and 20 healthy controls took part in the research. Cognitive functions were examined due to the Montreal Cognitive Assessment test – MoCA test. For the severity of psycho-emotional disorders evaluation the following scales and questionnaires were used: Night Sleep Assessment Questionnaire by A. M. Vein, Zung test for anxiety, apathy Starkstein scale, Boston stress-resistance test, Beck Depression Inventory (BDI-II). We performed ELISA test for determination of glutathione peroxidase (GPx) and glutathione-S-transferase (GST) activities and 3-nitrotyrosine (3-NT) level in blood plasma of participants (Elabscience® kit). Results. The middle age of PD patients and healthy controls was 64.35 ± 1.22 and 66.40 ± 0.70 years, respectively. GPx activity in plasma of patients at І–ІІ PD stages was significantly lower than in healthy controls (P < 0.001) and was higher at the I stage compared to the II PD stage (P = 0.003). Also GPx activity in PD patients with normal cognition was higher than in PD patients with cognitive impairment (P = 0.042). The GST activity in plasma of PD patients with anxiety was significantly lower (P = 0.002) compared to those without anxiety, and 3-NT blood plasma level in PD patients with moderate anxiety was higher than in those without one (P = 0.029). Conclusions. The activity of antioxidant GPx was significantly lower in PD patients at early stages compared to healthy controls, and in PD patients in the II stage of the disease compared to the I stage, and it was significantly lower in PD patients with cognitive impairment. PD patients with moderate anxiety had lower 3-NT levels and GST activity in blood plasma.http://pat.zsmu.edu.ua/article/view/233431/238838parkinson’s diseaseoxidative stressnitrosative stress
spellingShingle A. V. Demchenko
V. V. Biriuk
A. V. Abramov
The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
Patologìâ
parkinson’s disease
oxidative stress
nitrosative stress
title The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
title_full The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
title_fullStr The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
title_full_unstemmed The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
title_short The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
title_sort activity of markers of oxidative and nitrosative stresses in blood plasma of parkinson s disease patients at the early stages
topic parkinson’s disease
oxidative stress
nitrosative stress
url http://pat.zsmu.edu.ua/article/view/233431/238838
work_keys_str_mv AT avdemchenko theactivityofmarkersofoxidativeandnitrosativestressesinbloodplasmaofparkinsonsdiseasepatientsattheearlystages
AT vvbiriuk theactivityofmarkersofoxidativeandnitrosativestressesinbloodplasmaofparkinsonsdiseasepatientsattheearlystages
AT avabramov theactivityofmarkersofoxidativeandnitrosativestressesinbloodplasmaofparkinsonsdiseasepatientsattheearlystages
AT avdemchenko activityofmarkersofoxidativeandnitrosativestressesinbloodplasmaofparkinsonsdiseasepatientsattheearlystages
AT vvbiriuk activityofmarkersofoxidativeandnitrosativestressesinbloodplasmaofparkinsonsdiseasepatientsattheearlystages
AT avabramov activityofmarkersofoxidativeandnitrosativestressesinbloodplasmaofparkinsonsdiseasepatientsattheearlystages